No Picture

Hit by setbacks, Lundbeck’s Deborah Dunsire inks a $400M cannabinoid buyout, adding a discovery site

New Lundbeck CEO Deborah Dunsire is turning to M&A to build the pipeline.
Early Monday the Danish biotech reported that Dunsire had agreed to pay $250 million cash to snag San Diego-based Abide Therapeutics, where researchers have been working o… […]